ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease?

Nephrol Dial Transplant. 2001 Sep;16(9):1742-5. doi: 10.1093/ndt/16.9.1742.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Arginine / analogs & derivatives*
  • Arginine / physiology*
  • Arteriosclerosis / etiology*
  • Enzyme Inhibitors / metabolism
  • Humans
  • Kidney Diseases / complications*
  • Kidney Diseases / physiopathology*
  • Nitric Oxide Synthase / antagonists & inhibitors*

Substances

  • Enzyme Inhibitors
  • N,N-dimethylarginine
  • Arginine
  • Nitric Oxide Synthase